Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.5345 USD | +0.47% | +0.47% | +95.79% |
Kurzporträt
Mitarbeiterzahl: 29
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 01.07.07 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 23.12.12 |
Chief Tech/Sci/R&D Officer | - | 12.05.22 | |
Bob Dagher
CTO | Chief Tech/Sci/R&D Officer | 55 | 17.07.23 |
Yael Gothelf
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.07 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 01.06.20 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06.06.14 |
General Counsel | - | 12.05.22 | |
Mary Kay Turner
LAW | General Counsel | - | 07.08.17 |
Yossef Levy
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 22.09.00 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06.06.14 |
Jacob Frenkel
CHM | Chairman | 81 | 30.03.20 |
Director/Board Member | 63 | 28.10.21 | |
Director/Board Member | 61 | 05.02.18 | |
Stacy Lindborg
BRD | Director/Board Member | 53 | 01.06.20 |
Nir Naor
BRD | Director/Board Member | 50 | 20.06.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 68 341 857 | 59 284 308 ( 86,75 %) | 0 | 86,75 % |
Unternehmenskontakt
Brainstorm Cell Therapeutics, Inc.
1325 Avenue of Americas 28th floor
10019, New York
+201 488 0460
http://www.brainstorm-cell.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+95.79% | 36.36 Mio. | |
+1.51% | 42.59 Mrd. | |
+8.57% | 40.65 Mrd. | |
+49.22% | 40.57 Mrd. | |
-12.36% | 26.77 Mrd. | |
+8.92% | 24.81 Mrd. | |
-25.13% | 18.17 Mrd. | |
+29.17% | 12.05 Mrd. | |
-3.12% | 11.7 Mrd. | |
+6.35% | 11.1 Mrd. |
- Börse
- Aktien
- A12BXW Aktie
- Unternehmen Brainstorm Cell Therapeutics Inc.